CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | Coleman Glenn EVP & Chief Financial Officer | Purchase | +10 | $297.43 | $3K | 27,762 |
| 2026-03-03 | LaPlume Joseph W EVP, Corp Strategy & Develop | Purchase | +25 | $174.54 | $4K | 27,448 |
| 2025-02-20 | FOSTER JAMES C Chairman, President and CEO | Purchase | +6,075 | $165.01 | $1.0M | 183,639 |
| 2025-02-20 | Girshick Birgit Corporate Executive VP & COO | Purchase | +1,514 | $164.63 | $249K | 55,058 |
| 2023-11-20 | Girshick Birgit Corporate Executive VP & COO | Purchase | +1,322 | $187.82 | $248K | 44,449 |
| 2023-11-14 | FOSTER JAMES C Chairman, President and CEO | Purchase | +5,620 | $178.05 | $1.0M | 202,643 |
| 2023-08-24 | WALLMAN RICHARD F Director | Purchase | +1,000 | $198.79 | $199K | 1,000 |
Page 1 of 1 · 7 trades